ArticleMethods in molecular biology (Clifton, N.J.)2025
Molecular Imprinted Hydrogels for the Controlled and Sustained Release of Hydrophilic Drug Therapy.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogels can be used in many biomedical applications and can be imprinted with hydrophilic target molecules through hydrogen bonding. The imprinting process leaves a void space within the hydrogel matrix that includes both the shape and the functionality of the target molecules, thus enabling a thermodynamically favorable interaction between the target molecules and the hydrogel matrix. Our laboratory has developed a standard method for imprinting hydrophilic drug molecules into the hydrogel structure. While applications may include both drug delivery and signal recognition in chemical sensors, we report here on applications in drug delivery and the therapeutic treatment of ocular diseases by utilizing timolol maleate as the target molecule. Here, we describe the protocols we have developed for the preparation of molecular imprinted hydrogels for use in drug delivery applications.
Indexed as
Identifiers
40029600What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.